vs
AdvanSix Inc.（ASIX）与Aveanna Healthcare Holdings, Inc.（AVAH）财务数据对比。点击上方公司名可切换其他公司
Aveanna Healthcare Holdings, Inc.的季度营收约是AdvanSix Inc.的1.7倍（$621.9M vs $359.9M），Aveanna Healthcare Holdings, Inc.净利率更高（2.3% vs -0.8%，领先3.0%），Aveanna Healthcare Holdings, Inc.同比增速更快（22.2% vs 9.4%），过去两年Aveanna Healthcare Holdings, Inc.的营收复合增速更高（14.0% vs 3.4%）
AdvanSix Inc.是一家美国化工企业，主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部，于2016年分拆独立，2019年预估营收达14亿美元，其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
Aveanna Healthcare Holdings, Inc.是美国领先的家庭及社区医疗服务提供商，核心业务覆盖儿科家庭护理、成人个人照护、临终关怀、输液治疗等领域，通过覆盖全美的本地护理中心网络为各地患者提供服务，服务对象涵盖公共及私人付费群体。
ASIX vs AVAH — 直观对比
营收规模更大
AVAH
是对方的1.7倍
$359.9M
营收增速更快
AVAH
高出12.8%
9.4%
净利率更高
AVAH
高出3.0%
-0.8%
两年增速更快
AVAH
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $359.9M | $621.9M |
| 净利润 | $-2.8M | $14.1M |
| 毛利率 | 7.6% | 32.6% |
| 营业利润率 | -0.7% | 8.6% |
| 净利率 | -0.8% | 2.3% |
| 营收同比 | 9.4% | 22.2% |
| 净利润同比 | -892.9% | 132.8% |
| 每股收益（稀释后） | $-0.11 | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASIXAVAH
| Q4 25 | $359.9M | — | ||
| Q3 25 | $374.5M | $621.9M | ||
| Q2 25 | $410.0M | $589.6M | ||
| Q1 25 | $377.8M | $559.2M | ||
| Q4 24 | $329.1M | $519.9M | ||
| Q3 24 | $398.2M | $509.0M | ||
| Q2 24 | $453.5M | $505.0M | ||
| Q1 24 | $336.8M | $490.7M |
净利润ASIXAVAH
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-2.6M | $14.1M | ||
| Q2 25 | $31.4M | $27.0M | ||
| Q1 25 | $23.3M | $5.2M | ||
| Q4 24 | $352.0K | $29.2M | ||
| Q3 24 | $22.3M | $-42.8M | ||
| Q2 24 | $38.9M | $13.9M | ||
| Q1 24 | $-17.4M | $-11.2M |
毛利率ASIXAVAH
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | 32.6% | ||
| Q2 25 | 14.3% | 35.8% | ||
| Q1 25 | 14.2% | 32.8% | ||
| Q4 24 | 3.4% | 33.0% | ||
| Q3 24 | 14.4% | 31.4% | ||
| Q2 24 | 17.9% | 31.3% | ||
| Q1 24 | 0.9% | 29.7% |
营业利润率ASIXAVAH
| Q4 25 | -0.7% | — | ||
| Q3 25 | -0.9% | 8.6% | ||
| Q2 25 | 7.7% | 13.6% | ||
| Q1 25 | 7.7% | 9.3% | ||
| Q4 24 | -3.9% | 8.8% | ||
| Q3 24 | 7.5% | 6.7% | ||
| Q2 24 | 11.5% | 7.4% | ||
| Q1 24 | -7.0% | 4.7% |
净利率ASIXAVAH
| Q4 25 | -0.8% | — | ||
| Q3 25 | -0.7% | 2.3% | ||
| Q2 25 | 7.7% | 4.6% | ||
| Q1 25 | 6.2% | 0.9% | ||
| Q4 24 | 0.1% | 5.6% | ||
| Q3 24 | 5.6% | -8.4% | ||
| Q2 24 | 8.6% | 2.8% | ||
| Q1 24 | -5.2% | -2.3% |
每股收益（稀释后）ASIXAVAH
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.10 | $0.06 | ||
| Q2 25 | $1.15 | $0.13 | ||
| Q1 25 | $0.86 | $0.03 | ||
| Q4 24 | $0.02 | $0.15 | ||
| Q3 24 | $0.82 | $-0.22 | ||
| Q2 24 | $1.43 | $0.07 | ||
| Q1 24 | $-0.65 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $145.9M |
| 总债务越低越好 | — | $1.3B |
| 股东权益账面价值 | $815.2M | $9.2M |
| 总资产 | $1.7B | $1.8B |
| 负债/权益比越低杠杆越低 | — | 141.83× |
8季度趋势，按日历期对齐
现金及短期投资ASIXAVAH
| Q4 25 | $19.8M | — | ||
| Q3 25 | $23.7M | $145.9M | ||
| Q2 25 | $18.4M | $100.7M | ||
| Q1 25 | $8.3M | $71.5M | ||
| Q4 24 | $19.6M | $84.3M | ||
| Q3 24 | $17.3M | $78.5M | ||
| Q2 24 | $12.1M | $47.7M | ||
| Q1 24 | $20.6M | $42.6M |
总债务ASIXAVAH
| Q4 25 | — | — | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.3B |
股东权益ASIXAVAH
| Q4 25 | $815.2M | — | ||
| Q3 25 | $818.2M | $9.2M | ||
| Q2 25 | $823.7M | $-12.0M | ||
| Q1 25 | $794.4M | $-100.1M | ||
| Q4 24 | $774.6M | $-123.6M | ||
| Q3 24 | $766.4M | $-156.4M | ||
| Q2 24 | $746.6M | $-119.0M | ||
| Q1 24 | $713.2M | $-136.3M |
总资产ASIXAVAH
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | $1.8B | ||
| Q2 25 | $1.6B | $1.8B | ||
| Q1 25 | $1.6B | $1.7B | ||
| Q4 24 | $1.6B | $1.7B | ||
| Q3 24 | $1.5B | $1.6B | ||
| Q2 24 | $1.5B | $1.7B | ||
| Q1 24 | $1.5B | $1.6B |
负债/权益比ASIXAVAH
| Q4 25 | — | — | ||
| Q3 25 | — | 141.83× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.7M | $33.2M |
| 自由现金流经营现金流 - 资本支出 | $36.1M | — |
| 自由现金流率自由现金流/营收 | 10.0% | — |
| 资本支出强度资本支出/营收 | 7.7% | — |
| 现金转化率经营现金流/净利润 | — | 2.36× |
| 过去12个月自由现金流最近4个季度 | $6.4M | — |
8季度趋势，按日历期对齐
经营现金流ASIXAVAH
| Q4 25 | $63.7M | — | ||
| Q3 25 | $26.6M | $33.2M | ||
| Q2 25 | $21.1M | $51.6M | ||
| Q1 25 | $11.4M | $-8.6M | ||
| Q4 24 | $64.2M | $13.4M | ||
| Q3 24 | $57.3M | $29.4M | ||
| Q2 24 | $50.2M | $1.8M | ||
| Q1 24 | $-36.2M | $-12.0M |
自由现金流ASIXAVAH
| Q4 25 | $36.1M | — | ||
| Q3 25 | $66.0K | — | ||
| Q2 25 | $-7.2M | — | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $29.8M | — | ||
| Q3 24 | $26.8M | — | ||
| Q2 24 | $16.7M | — | ||
| Q1 24 | $-71.6M | — |
自由现金流率ASIXAVAH
| Q4 25 | 10.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | -6.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | -21.3% | — |
资本支出强度ASIXAVAH
| Q4 25 | 7.7% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 7.4% | — | ||
| Q1 24 | 10.5% | — |
现金转化率ASIXAVAH
| Q4 25 | — | — | ||
| Q3 25 | — | 2.36× | ||
| Q2 25 | 0.67× | 1.91× | ||
| Q1 25 | 0.49× | -1.66× | ||
| Q4 24 | 182.29× | 0.46× | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | 0.13× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
AVAH
| Private Duty Services | $514.4M | 83% |
| Home Health And Hospice | $62.4M | 10% |
| Medical Solutions | $45.1M | 7% |
